Prognostic Impact of BRAF and KRAS Mutation in Patients with Colorectal and Appendiceal Peritoneal Metastases Scheduled for CRS and HIPEC.

Graf, Wilhelm

Prognostic Impact of BRAF and KRAS Mutation in Patients with Colorectal and Appendiceal Peritoneal Metastases Scheduled for CRS and HIPEC. [electronic resource] - Annals of surgical oncology Jan 2020 - 293-300 p. digital

Publication Type: Journal Article

1534-4681

10.1245/s10434-019-07452-2 doi


Adenocarcinoma--genetics
Aged
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Appendiceal Neoplasms--genetics
Biomarkers, Tumor--genetics
Colorectal Neoplasms--genetics
Combined Modality Therapy
Cytoreduction Surgical Procedures
Female
Humans
Hyperthermia, Induced
Male
Middle Aged
Mutation
Peritoneal Neoplasms--secondary
Prognosis
Proto-Oncogene Proteins B-raf--genetics
Proto-Oncogene Proteins p21(ras)--genetics
Survival Rate